Global Information
회사소개 | 문의 | 비교리스트

조루 치료제 시장 : 세계 시장 예측(-2026년)

Premature Ejaculation Treatment Market - Global Forecast to 2026

리서치사 Coherent Market Insights
발행일 2018년 07월 상품 코드 785768
페이지 정보 영문
가격
US $ 4,500 ₩ 5,315,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,269,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,813,000 PPT Turned PDF (Enterprise User License)


조루 치료제 시장 : 세계 시장 예측(-2026년) Premature Ejaculation Treatment Market - Global Forecast to 2026
발행일 : 2018년 07월 페이지 정보 : 영문

조루는 일반적인 문제이지만 정확한 원인은 알려져 있지 않습니다. 조기의 성적 경험, 성적 학대, 빈약한 신체상, 우울증, 불안, 호르몬 수치 이상, 유전, 전립선 및 요도의 염증·감염증, 심리적 불안 등의 요인이 원인으로 여겨지고 있습니다.

세계의 조루 치료제(Premature Ejaculation Treatment) 시장을 조사했으며, 시장 개요, 의약품 종류·투여 경로·제형·유통 채널·지역별 시장 규모 추정과 예측, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 가정

  • 조사 목적
  • 가정
  • 약어

제2장 시장 범위

  • 보고서 개요
  • 시장 정의와 범위
  • 주요 요약
  • 시장 정보 : 의약품 종류별
  • 시장 정보 : 투여 경로별
  • 시장 정보 : 제형별
  • 시장 정보 : 유통 채널별
  • 시장 정보 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 성장 촉진요인
  • 성장 저해요인
  • 시장 기회
  • PEST 분석
  • 파이프라인 분석
  • 제품 승인
  • 제품 발매
  • 제휴·인수
  • Porter's Five Forces 분석

제4장 세계의 조루 치료제 시장 : 의약품 종류별

  • 서론
    • 시장 점유율 분석
    • 전년대비 성장률
  • 선택적 세로토닌 재흡수 억제제(SSRI)
  • 포스포디에스테라아제 5형(PDE5) 억제제
  • 국소 마취제
  • 기타

제5장 세계의 조루 치료제 시장 : 투여 경로별

  • 서론
    • 시장 점유율 분석
    • 전년대비 성장률
  • 경구
  • 국소

제6장 세계의 조루 치료제 시장 : 제형별

  • 서론
    • 시장 점유율 분석
    • 전년대비 성장률
  • 정제
  • 스프레이
  • 기타

제7장 세계의 조루 치료제 시장 : 유통 채널별

  • 서론
    • 시장 점유율 분석
    • 전년대비 성장률
    • 부문 동향
  • 병원
  • 온라인 약국
  • 소매 약국

제8장 세계의 조루 치료제 시장 : 지역별

  • 서론
    • 시장 점유율 분석
    • 전년대비 성장률
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 프랑스
    • 스페인
    • 러시아
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • ASEAN 국가
    • 호주
    • 한국
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타
  • 아프리카
    • 중앙아프리카
    • 남아프리카
    • 북아프리카
  • 중동
    • 걸프협력회의(GCC)
    • 이스라엘
    • 기타

제9장 경쟁 상황

  • 히트맵 해석
  • 기업 개요
  • Regent Pacific Group Limited
  • Menarini Group
  • Furiex Pharmaceuticals, Inc.
  • Absorption Pharmaceuticals, LLC
  • Ampio Pharmaceuticals, Inc.
  • Aytu BioScience
  • NeuroHealing Pharmaceuticals Inc.
  • Dong-A Pharmaceutical Co., Ltd.

제10장 부록

  • 참고 문헌
  • 조사 방법
  • Coherent Market Insights 소개
KSM 19.02.28

Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

Market Dynamics

Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.

Key features of the study:

This report provides in-depth analysis of premature ejaculation treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global premature ejaculation treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans

Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics

The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market

Detailed Segmentation:

  • Global Premature Ejaculation Treatment Market, By Drug Type :
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Dapoxetine
  • Others
  • Phosphodiesterase Type 5 (PDE5) Inhibitors
  • Zertane
  • Others
  • Topical Anesthetics
  • Others
  • Global Premature Ejaculation Treatment Market, By Route of Administration:
  • Oral
  • Topical
  • Global Premature Ejaculation Treatment Market, By Dosage Form:
  • Pills
  • Spray
  • Others
  • Global Premature Ejaculation Treatment Market, By Distribution Channel:
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
  • Global Premature Ejaculation Treatment Market, By Geography:
  • North America
  • Drug Type:
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Dapoxetine
  • Others
  • Phosphodiesterase Type 5 (PDE5) Inhibitors
  • Zertane
  • Others
  • Topical Anesthetics
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • By Dosage Form
  • Pills
  • Spray
  • Others
  • By Distribution Channel
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Europe
  • Drug Type:
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Dapoxetine
  • Others
  • Phosphodiesterase Type 5 (PDE5) Inhibitors
  • Zertane
  • Others
  • Topical Anesthetics
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • By Dosage Form
  • Pills
  • Spray
  • Others
  • By Distribution Channel
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Drug Type:
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Dapoxetine
  • Others
  • Phosphodiesterase Type 5 (PDE5) Inhibitors
  • Zertane
  • Others
  • Topical Anesthetics
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • By Dosage Form
  • Pills
  • Spray
  • Others
  • By Distribution Channel
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Drug Type:
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Dapoxetine
  • Others
  • Phosphodiesterase Type 5 (PDE5) Inhibitors
  • Zertane
  • Others
  • Topical Anesthetics
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • By Dosage Form
  • Pills
  • Spray
  • Others
  • By Distribution Channel
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • Drug Type:
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Dapoxetine
  • Others
  • Phosphodiesterase Type 5 (PDE5) Inhibitors
  • Zertane
  • Others
  • Topical Anesthetics
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • By Dosage Form
  • Pills
  • Spray
  • Others
  • By Distribution Channel
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Drug Type:
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Dapoxetine
  • Others
  • Phosphodiesterase Type 5 (PDE5) Inhibitors
  • Zertane
  • Others
  • Topical Anesthetics
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • By Dosage Form
  • Pills
  • Spray
  • Others
  • By Distribution Channel
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Regent Pacific Group Limited *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Menarini Group
  • Furiex Pharmaceuticals, Inc.
  • Absorption Pharmaceuticals, LLC
  • Ampio Pharmaceuticals, Inc.
  • Aytu BioScience
  • NeuroHealing Pharmaceuticals Inc.
  • Dong-A Pharmaceutical Co., Ltd.
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Dosage Form
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • PEST Analysis
    • Pipeline Analysis
    • Product Approval
    • Product Launch
    • Collaboration-Acquisition
    • Porter's Five Forces Analysis

4. Global Premature Ejaculation Treatment Market, By Drug Type, 2016 - 2026 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Selective Serotonin Reuptake Inhibitors (SSRIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
    • Segment Trends
    • Dapoxetine
    • Others
    • Phosphodiesterase Type 5 (PDE5) Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
    • Segment Trends
    • Zertane
    • Others
    • Topical Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2016 - 2026 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
    • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

6. Global Premature Ejaculation Treatment Market, Dosage Form, 2016 - 2026 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
    • Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
    • Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2016 - 2026 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

8. Global Premature Ejaculation Treatment Market, By Region, 2016 - 2026 (US$ Bn)

    • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
    • North America
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
    • U.S.
    • Canada
    • Europe
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Africa
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
    • Central Africa
    • South Africa
    • North Africa
    • Middle East
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
    • Regent Pacific Group Limited
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Menarini Group
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Furiex Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Absorption Pharmaceuticals, LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Ampio Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Aytu BioScience
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • NeuroHealing Pharmaceuticals Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Dong-A Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Back to Top
전화 문의
F A Q